2667-0496

Neurology Perspectives

Elsevier

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2625 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2625 DOIs
2

Attach ORCID iDs across 2625 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact2625 DOIs
3

Deposit reference lists for 2415 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact2415 DOIs

DOIs for this ISSN

Showing the top 5 of 2625 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cognitive symptoms after COVID-19 (10.1016/j.neurop.2021.10.005)
Abstract ORCID
84.06 47
2 Deep brain stimulation in neurological diseases and other pa… (10.1016/j.neurop.2022.03.001)
Abstract ORCID
70.75 25
3 Brain abscess: A narrative review (10.1016/j.neurop.2022.01.010)
Abstract ORCID
68.09 22
4 Persistent headache after COVID-19: Pathophysioloy, clinic a… (10.1016/j.neurop.2021.10.003)
Abstract ORCID
65.05 19
5 Epidemiology, pathophysiology, and classification of the neu… (10.1016/j.neurop.2021.07.005)
Abstract ORCID
62.76 17
6 Genetics of Parkinson's disease: Dominant forms and GBA (10.1016/j.neurop.2024.100153)
Abstract ORCID
62.76 17
7 Ortho-coumaric acid derivatives with therapeutic potential i… (10.1016/j.neurop.2021.09.006)
Abstract ORCID
57.31 13
8 Latest research on the anatomy and physiology of the cerebel… (10.1016/j.neurop.2021.12.002)
Abstract ORCID
55.70 12
9 Guillain-Barre syndrome after vaccination for Covid-19. The… (10.1016/j.neurop.2021.09.002)
Abstract ORCID
53.96 11
10 Biomaterials: Emerging systems for study and treatment of gl… (10.1016/j.neurop.2021.12.001)
Abstract ORCID
53.96 11
11 New insights into epigenetics as an influencer: An associati… (10.1016/j.neurop.2022.01.002)
Abstract ORCID
53.96 11
12 Physical fatigue and perceived fatigability in adolescents a… (10.1016/j.neurop.2022.06.008)
Abstract ORCID
52.07 10
13 Prevalence of neurological manifestations in COVID-19 and th… (10.1016/j.neurop.2021.03.002)
Abstract ORCID
50.00 9
14 Parkinson's disease: Present and future of cell therapy (10.1016/j.neurop.2021.07.006)
Abstract ORCID
50.00 9
15 Post-COVID symptoms of potential peripheral nervous and musc… (10.1016/j.neurop.2021.11.002)
Abstract ORCID
47.71 8
16 Neurotoxicity of aluminium chloride and okadaic acid in zebr… (10.1016/j.neurop.2024.100180)
Abstract ORCID
47.71 8
17 Genetics of Parkinson´s disease: Recessive forms (10.1016/j.neurop.2024.100147)
Abstract ORCID
45.15 7
18 Síndrome de Guillain-Barré asociado a COVID-19: diagnóstico,… (10.1016/j.neurop.2021.03.003)
Abstract ORCID
42.25 6
19 Diagnóstico neuropsicológico diferencial en enfermedad de Al… (10.1016/j.neurop.2021.03.004)
Abstract ORCID
42.25 6
20 Genetic characterization of Limb Girdle Muscular Dystrophies… (10.1016/j.neurop.2022.03.003)
Abstract ORCID
42.25 6
21 Similarities and differences between migraine and other type… (10.1016/j.neurop.2023.100122)
Abstract ORCID
42.25 6
22 Consensus document for lipid profile determination and repor… (10.1016/j.neurop.2023.100126)
Abstract ORCID
42.25 6
23 Mitochondrial function and epigenetic outlook in Leber's Her… (10.1016/j.neurop.2021.07.003)
Abstract ORCID
38.91 5
24 The challenges of the bioactive scaffolds in nervous system:… (10.1016/j.neurop.2021.07.007)
Abstract ORCID
38.91 5
25 Cognitive impairment in adults with autoimmune encephalitis:… (10.1016/j.neurop.2022.01.004)
Abstract ORCID
38.91 5
26 Can COVID-19 pandemic worsen previous neurological/psychiatr… (10.1016/j.neurop.2022.06.002)
Abstract ORCID
38.91 5
27 HaNDL syndrome after COVID-19 (10.1016/j.neurop.2022.06.007)
Abstract ORCID
38.91 5
28 Animal models in Alzheimer's disease: Biological plausibilit… (10.1016/j.neurop.2023.100110)
Abstract ORCID
38.91 5
29 Polyneuropathy in a pregnant woman with hyperemesis gravidar… (10.1016/j.neurop.2023.100132)
Abstract ORCID
38.91 5
30 Predictors of mortality in dementia: A systematic review and… (10.1016/j.neurop.2024.100175)
Abstract ORCID
38.91 5
31 Functional cognitive disorder: Beyond pseudodementia (10.1016/j.neurop.2024.100179)
Abstract ORCID
38.91 5
32 Association of depression in multiple sclerosis with fatigue… (10.1016/j.neurop.2024.100181)
Abstract ORCID
38.91 5
33 20393. COMBINACIÓN DE ESTIMULACIÓN TRANSCRANEAL DE CORRIENTE… (10.1016/s2667-0496(24)00343-0)
Abstract References ORCID
35.78 2
34 Volumetric measurement of the hippocampus in a series of pat… (10.1016/j.neurop.2021.05.005)
Abstract ORCID
34.95 4
35 Eating habits of patients with multiple sclerosis in three d… (10.1016/j.neurop.2021.07.001)
Abstract ORCID
34.95 4
36 Neurological complications of liver transplantation in paedi… (10.1016/j.neurop.2021.10.007)
Abstract ORCID
34.95 4
37 Post–COVID-19 neurological symptoms (10.1016/j.neurop.2021.11.001)
Abstract ORCID
34.95 4
38 Heat stroke with neurological involvement (10.1016/j.neurop.2022.08.004)
Abstract ORCID
34.95 4
39 Autoimmune-associated epilepsy in an outpatient epilepsy cli… (10.1016/j.neurop.2023.100144)
Abstract ORCID
34.95 4
40 Aproximación al estudio del deterioro cognitivo en la escler… (10.1016/j.neurop.2021.03.006)
Abstract ORCID
30.10 3
41 Repercusión de la pandemia por COVID-19 en la formación de l… (10.1016/j.neurop.2021.04.004)
Abstract ORCID
30.10 3
42 Potential therapeutic applications of stem cell therapy for… (10.1016/j.neurop.2021.07.004)
Abstract ORCID
30.10 3
43 Efficacy of a telemedicine programme in the treatment of pae… (10.1016/j.neurop.2021.08.004)
Abstract ORCID
30.10 3
44 Role of microglia in the pathophysiology of neuropathic pain… (10.1016/j.neurop.2021.09.004)
Abstract ORCID
30.10 3
45 Prevalence study of multiple sclerosis in the Spanish provin… (10.1016/j.neurop.2021.11.006)
Abstract ORCID
30.10 3
46 Applications of vitamin C for pain management: neurological… (10.1016/j.neurop.2022.01.007)
Abstract ORCID
30.10 3
47 Experience with erenumab: Data from real clinical practice (10.1016/j.neurop.2022.01.009)
Abstract ORCID
30.10 3
48 Acute motor axonal neuropathy associated with the Pfizer SAR… (10.1016/j.neurop.2022.06.005)
Abstract ORCID
30.10 3
49 Multiple ischaemic strokes and encephalopathy in a patient w… (10.1016/j.neurop.2022.06.006)
Abstract ORCID
30.10 3
50 First report of spastic ataxia of Charlevoix-Saguenay cases… (10.1016/j.neurop.2022.07.002)
Abstract ORCID
30.10 3